Outcomes associated with influenza vaccination in the first year after kidney transplantation

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 5, 2011, Pages 1192-1197

  Hurst, Frank P ^a   Lee, Jessica J ^a   Jindal, Rahul M ^b   Agodoa, Lawrence Y ^c   Abbott, Kevin C ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; INFLUENZA VACCINE; MYCOPHENOLIC ACID; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; DEATH; DEMOGRAPHY; FEMALE; GRAFT FAILURE; HEALTH CARE UTILIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INFLUENZA VACCINATION; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, VIRAL; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA VACCINES; INFLUENZA, HUMAN; KIDNEY TRANSPLANTATION; MALE; MEDICARE; MIDDLE AGED; REGISTRIES; SEROEPIDEMIOLOGIC STUDIES; TRANSPLANTATION, HOMOLOGOUS; UNITED STATES;

EID: 79957816806     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.05430610     Document Type: Article

References (17)

1. Nichols WG, Guthrie KA, Corey L, Boeckh M: Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 39: 1300-1306, 2004
2. Scharpe ́ J, Evenepoel P, Maes B, Bammens B, Claes K, Osterhaus AD, Vanrenterghem Y, Peetermans WE: Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 8: 332-337, 2008
3. Danzinger-Isakov L, Kumar D: AST Infectious Diseases Community of Practice: Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 9[Suppl 4]: S258-S262, 2009
4. Birdwell KA, Ikizler MR, Sannella EC, Wang L, Byrne DW, Ikizler TA, Wright PF: Decreased antibody response to influenza vaccination in kidney transplantrecipients: A prospective cohort study. Am J Kidney Dis 54: 112-121, 2009
5. Salles MJ, Sens YA, Boas LS, Machado CM: Influenza virus vaccination in kidneytransplant recipients: Serum antibody response to different immunosuppressive drugs. Clin Transplant 24:, 2010
6. Briggs JD, Timbury MC, Paton AM, Bell PRF: Viral infection and renal transplant rejection. BMJ 4: 520-522, 1972
7. David DS, Millian SJ, Whitsell JC, Schwartz GH, Riggio RR, Stenzel KH, Rubin AL: Viral syndromes and renal homograft rejection. Ann Surg 175: 257-259, 1972
8. Keshtkar-Jahromi M, Argani H, Rahnavardi M, Mirchi E, Atabak S, Tara SA, Gachkar L, Noori-Froothghe A, Mokhtari-Azad T: Antibody response to influenza immunization in kid ney transplant recipients receiving either azathioprine or mycophenolate: A controlled trial. Am J Nephrol 28: 654-660, 2008
9. Wyzgał J, Brydak LB, Zygier D, Paczek L, Rowinski W, Grochowiecki T: Study on efficacy of influenza vaccination in renal allograft recipients. Transplant Proc 34: 572-575, 2002
10. Grekas D, Alivanis P, Kiriazopoulou V, Dioudis C, Sioulis A, Derveniotis V, Tourkantonis A: Influenza vaccination on renal transplant patients is safe and serologically effective. Int J Clin Pharmacol Ther Toxicol 31: 553-556, 1993
11. Gilbertson DT, Unruh M, McBean AM, Kausz AT, Snyder JJ, Collins AJ: Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int 63: 738-743, 2003
12. Snyder JJ, Collins AJ: Association of preventive health care with atherosclerotic heart disease and mortality in CKD. J Am Soc Nephrol 20: 1614-1622, 2009
13. Berben L, Denhaerynck K, Schaub S, De Geest S: Prevalence and correlates of influenza vaccination among kidney transplant patients. Prog. Transplantation 19: 312-317, 2009
14. Harris K, Baggs J, Davis RL, Black S, Jackson LA, Mullooly JP, Chapman LE: Influenza vaccination coverage among adult solid organ transplant recipients at three health maintenance organizations, 1995-2005. Vaccine 27: 2335-2341, 2009
15. Batiuk TD, Bodziak KA, Goldman M: Infectious disease prophylaxis in renal transplant patients: A survey of US transplant centers. Clin Transplant 16: 1-8, 2002
16. Willcocks LC, Chaudhry AN, Smith JC, Ojha S, Doffinger R, Watson CJE, Smith KGC: The effect of sirolimus therapy on vaccine responses in transplant patients. Am J Transplant 7: 2006-2011, 2007
17. Abbott KC, Bucci JR, Cruess D, Taylor AJ, Agodoa LY: Graft loss and acute coronary syndromes after renal transplantation in the United States. J Am Soc Nephrol 13: 2560-2569, 2002